Drug and Medication Analysis & Statistics, January 2015 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

571-600 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

Shanghai Modern Pharmaceutical Co., Ltd. (Symbol:600420) SWOT Analysis, Strategy, Revenues and Profits

Shanghai Modern Pharmaceutical Co., Ltd. (Symbol:600420) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : China
Shenzhen Cau Technology Co., Ltd. (Symbol:000004) SWOT Analysis, Strategy, Revenues and Profits

Shenzhen Cau Technology Co., Ltd. (Symbol:000004) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
Shenzhen Salubris Pharmaceuticals Co., Ltd. (Symbol:002294) SWOT Analysis, Strategy, Revenues and Profits

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Symbol:002294) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (Symbol:8329) SWOT Analysis, Strategy, Revenues and Profits

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (Symbol:8329) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United States
Syn-Tech Chem. & Pharm. Co., Ltd. (Symbol:1777) SWOT Analysis, Strategy, Revenues and Profits

Syn-Tech Chem. & Pharm. Co., Ltd. (Symbol:1777) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
Syncom Formulations (Symbol:India) SWOT Analysis, Strategy, Revenues and Profits

Syncom Formulations (Symbol:India) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : India
Synmosa Biopharma Corporation (Symbol:4114) SWOT Analysis, Strategy, Revenues and Profits

Synmosa Biopharma Corporation (Symbol:4114) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Taiwan, South Africa
Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Sanofi India Limited (Sanofi India) is a pharmaceutical company. The company provides medicines for the treatment of patients with cardiovascular disease, thrombotic diseases, metabolic disorders, ...

  • Industries : Drug and Medication
  • Countries : India
The United Laboratories International Holdings Limited (Symbol:3933) SWOT Analysis, Strategy, Revenues and Profits

The United Laboratories International Holdings Limited (Symbol:3933) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
Theravance, Inc. (Symbol:THRX) SWOT Analysis, Strategy, Revenues and Profits

Theravance, Inc. (Symbol:THRX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United States
Shanghai Fosun Pharmaceutical (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

Shanghai Fosun Pharmaceutical (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : China
Krebs Biochemicals & Industries Ltd (Symbol:524518 ) SWOT Analysis, Strategy, Revenues and Profits

Krebs Biochemicals & Industries Ltd (Symbol:524518 ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
RPG Life Sciences Limited (Symbol:RPGLIFE) SWOT Analysis, Strategy, Revenues and Profits

RPG Life Sciences Limited (Symbol:RPGLIFE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : India
Neuland Laboratories Limited (NEULANDLAB) - Financial and Strategic SWOT Analysis Review

Neuland Laboratories Limited (NEULANDLAB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Neuland Laboratories Limited (Neuland Lab) is a pharmaceutical company. It manufactures active pharmaceutical ingredients and advanced intermediates. The product line of the company includes salbutanol ...

  • Industries : Drug and Medication
Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis Review

Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Kopran Limited (Kopran) is an integrated pharmaceutical company. It is a group company of Parijat Enterprises. The company manufactures both active pharmaceutical ingredients (APIs) and finished ...

  • Industries : Drug and Medication
Venus Remedies Limited (VENUSREM) - Financial and Strategic SWOT Analysis Review

Venus Remedies Limited (VENUSREM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Venus Remedies Limited (Venus) is a pharmaceutical company. It develops, manufactures and commercializes pharmaceutical products. The company, through its research centre Venus Medicine Research ...

  • Industries : Drug and Medication
  • Countries : India, Germany, Australia
Suven Life Sciences Ltd. (SUVEN) - Financial and Strategic SWOT Analysis Review

Suven Life Sciences Ltd. (SUVEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Suven Life Sciences Ltd (Suven) is a biopharmaceutical company. The company designs, manufactures and supplies API's, advanced intermediates, and fine chemicals for the life science industry. Its ...

  • Industries : Drug and Medication
  • Countries : New Zealand, South Korea, Australia, Singapore
Sagent Pharmaceuticals, Inc. (SGNT) - Financial and Strategic SWOT Analysis Review

Sagent Pharmaceuticals, Inc. (SGNT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Sagent Pharmaceuticals, Inc. (Sagent) is a specialty pharmaceutical company. It focuses on the development and manufacture of pharmaceutical products with specific focus on injectables. The company's ...

  • Industries : Drug and Medication
  • Countries : United States
Kilitch Drugs (India) Ltd. (KILITCH) - Financial and Strategic SWOT Analysis Review

Kilitch Drugs (India) Ltd. (KILITCH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Kilitch Drugs (India) Ltd. (Kilitch) is a pharmaceutical company. The company manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. Its products include ...

  • Industries : Drug and Medication
  • Countries : India
Claris Lifesciences Limited (533288) - Financial and Strategic SWOT Analysis Review

Claris Lifesciences Limited (533288) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Claris Lifesciences Limited (Claris) is an Indian based sterile injectables pharmaceutical company. The company manufactures and markets products across multiple markets, and therapeutic segments. ...

  • Industries : Drug and Medication
  • Countries : India
BG Medicine, Inc. (BGMD) - Financial and Strategic SWOT Analysis Review

BG Medicine, Inc. (BGMD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary BG Medicine, Inc. (BGM) is a life science company. The company discovers, develops and delivers diagnostic solutions to aid in the clinical management of heart failure and related disorders. Its ...

  • Industries : Drug and Medication
  • Countries : United States
CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary CCM Duopharma Biotech Bhd. (CCM Duopharma) is an investment holding company. The company conducts manufacturing, distributing, importing, and exporting of pharmaceutical products and medicines. ...

  • Industries : Drug and Medication
  • Countries : Yemen, Asia, Papua New Guinea, Sri Lanka, Singapore, Bangladesh
Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review

Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Aarti Drugs Ltd. (ADL) is a pharmaceutical company. It carries out the development and manufacture of generic bulk actives, advanced intermediates and specialty chemicals. ADL's product portfolio ...

  • Industries : Drug and Medication
Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Adimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company's vaccine products include Japan ...

  • Industries : Drug and Medication
  • Countries : Japan, Taiwan
Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis Review

Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Bliss GVS Pharma Limited (Bliss GVS) is a generic pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical formulations. The company holds expertise ...

  • Industries : Drug and Medication
  • Countries : India
FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary FDC Limited (FDC) is a pharmaceutical company. The company manufactures and sells various healthcare products. The products of the company include therapeutic index: anti fungals/dermatological, ...

  • Industries : Drug and Medication
  • Countries : India
IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary IPCA Laboratories Limited (IPCA) is a generic pharmaceutical company. It undertakes the manufacturing and distribution of active pharmaceutical ingredients (APIs) and formulations. The company's ...

  • Industries : Drug and Medication
  • Countries : Australia
Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Parabolic Drugs Limited (PDL) is a pharmaceutical intermediate company. The company focuses on development and manufacturing of APIs (Active Pharmaceutical Ingredients) and API intermediates. It ...

  • Industries : Drug and Medication
  • Countries : World
Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Surya Pharmaceutical Limited (Surya Pharmaceutical) is a pharmaceutical company. The company discovers, produces and markets active pharmaceutical ingredients (APIs), finished drug formulations ...

  • Industries : Drug and Medication
  • Countries : Singapore, United States

62 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.